Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

by Dr. Trupti Shirole on  November 10, 2016 at 6:40 AM Heart Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

Treatment with high-dose statins results in plaque stabilization, suggests previous study. Researchers at the Mount Sinai Cardiac Catheterization Lab have found that patients treated with intensive statin therapy undergo changes in plaque morphology, specifically a thickening of the fibrous cap, that are associated with improved cholesterol transport and distinct genomic changes.
 Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients
Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

The results of this study, titled YELLOW II (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy), were published in the Journal of the American College of Cardiology.

"While previous studies including our own have shown that treatment with high-dose statins results in plaque stabilization, we wanted to explore the mechanistic basis of changes in plaque morphology, especially focusing on how is the fat removed from the plaque," said lead investigator Annapoorna Kini, Director of the Cardiac Catheterization Laboratory at Mount Sinai Heart.

"Our results are promising and provide a wider snapshot of how high-dose statin therapy exerts its influence, and points to underlying changes in gene expression that result from treatment. We see many patients who develop blockages, despite taking their medications and improving their LDL cholesterol levels and blood chemistry. We're optimistic this research will help lead to future answers."

The study included 85 patients with stable multivessel coronary artery disease who underwent PCI for a culprit lesion. Patients also underwent multimodality imaging of an obstructive nonculprit lesion with optical coherence tomography (OCT), near-infrared spectroscopy, and intravascular ultrasound (IVUS). Cholesterol efflux capacity (CEC) was assessed. Following enrollment, patients were treated with high doses of rosuvastatin for eight to 12 weeks and then follow-up imaging, CEC and genomic changes were reassessed.

In addition to markedly lower bad cholesterol, inflammation and improved cholesterol efflux, the researchers also evaluated gene expression in isolated samples of peripheral blood mononuclear cells before and after high-dose statin therapy. They identified six differentially expressed genes which were involved in cholesterol synthesis (SQLE), regulation of fatty acid unsaturation (FADS1), cellular cholesterol uptake (LDLR), cholesterol efflux (ABCA1, ABCG1), and inflammation (DHCR24).

"The transcriptomic research is an attempt to isolate specific genomic biomarkers that might one day be used to identify responders to statin therapy, without the need for invasive imaging," said Joel Dudley, Associate Professor of Genetics and Genomic Sciences and Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai.

Dr. Narula, the director of imaging services at Sinai added that "this study was a unique attempt at bring the best of clinical, intravascular imaging, cell biology and genomic studies together. This is the true example of the translational science as best as it gets."

"This study was able to recruit 85 patients in a short time from a single center for this very involved research effort. It is a monumental feat and speaks high of Mount Sinai Catheterization laboratory which carries out the largest number of interventions in the country with the best safety data," said study author Samin K. Sharma, Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital. "This study has now demonstrated that Sinai cath lab can deliver the quality research at the same level as it has done so for outstanding patient care."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Most Popular On Medindia:

Recommended Reading

More News on:

Cholesterol High Cholesterol Heart Attack Diet Lifestyle and Heart Disease Body Mass Index Cholesterol - The Enigma Chemical Liposuction Heart Attack- Lifestyle Risks Statins Low Saturated Fat and Low Cholesterol Diet 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive